UNCY · Categories · Form 4

UNCY - SEC Form 4 insider transactions

Unicycive Therapeutics Inc. (UNCY) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for UNCY

• 20d
  SEC Form 4 filed by Director Kenkare-Mitra Sara

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 20d
  SEC Form 4 filed by CEO Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 21d
  SEC Form 4 filed by EVP, Corporate Strategy Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 21d
  SEC Form 4 filed by CFO Townsend John

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 21d
  SEC Form 4 filed by EVP, Pharmaceuticals and BD Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 22d
  SEC Form 4 filed by Director Laumas Sandeep

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 288d
  Director Aggarwal Gaurav converted options into 652,900 shares (SEC Form 4)

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 315d
  SEC Form 4 filed by Director Kenkare-Mitra Sara

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 315d
  SEC Form 4 filed by EVP of Corporate Strategy Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 315d
  SEC Form 4 filed by CEO Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 315d
  SEC Form 4 filed by Director Laumas Sandeep

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 315d
  SEC Form 4 filed by EVP, Pharmaceuticals and BD Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 315d
  SEC Form 4 filed by Director Aggarwal Gaurav

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 315d
  SEC Form 4 filed by Chief Financial Officer Townsend John

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 476d
  Director Aggarwal Gaurav converted options into 1,400,000 shares (SEC Form 4)

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 608d
  Director Aggarwal Gaurav converted options into 5,500,000 shares (SEC Form 4)

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 665d
  SEC Form 4 filed by Chief Financial Officer Townsend John

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 665d
  SEC Form 4 filed by EVP, Pharmaceuticals and BD Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 665d
  SEC Form 4 filed by CEO Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 665d
  SEC Form 4 filed by EVP of Corporate Strategy Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 784d
  SEC Form 4 filed by Townsend John

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 784d
  SEC Form 4 filed by Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 784d
  SEC Form 4 filed by Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 784d
  SEC Form 4 filed by Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1007d
  SEC Form 4 filed by Laumas Sandeep

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1007d
  SEC Form 4 filed by Kenkare-Mitra Sara

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1007d
  SEC Form 4 filed by Ryan John L

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1007d
  SEC Form 4 filed by Aggarwal Gaurav

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1015d
  SEC Form 4 filed by Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1015d
  SEC Form 4 filed by Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1015d
  SEC Form 4 filed by Townsend John

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1015d
  SEC Form 4 filed by Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1062d
  SEC Form 4 filed by Aggarwal Gaurav

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1062d
  SEC Form 4 filed by Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1063d
  SEC Form 4 filed by Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1063d
  SEC Form 4 filed by Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1148d
  SEC Form 4 filed by Schiller Brigitte (Amendment)

  4/A - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1188d
  SEC Form 4 filed by Aggarwal Gaurav

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1188d
  SEC Form 4 filed by Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1188d
  SEC Form 4 filed by Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1188d
  SEC Form 4 filed by Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1295d
  SEC Form 4 filed by Gupta Pramod

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1295d
  SEC Form 4 filed by Jermasek Douglas

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1295d
  SEC Form 4 filed by Gupta Shalabh K.

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1295d
  SEC Form 4 filed by Townsend John

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1380d
  SEC Form 4: Schiller Brigitte converted options into 26,738 shares

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)
• 1485d
  SEC Form 4: Schiller Brigitte bought $12,375 worth of shares (15,000 units at $0.82)

  4 - Unicycive Therapeutics, Inc. (0001766140) (Issuer)

Other UNCY categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends